SCHEMBL23618147

SCHEMBL23618147

Nc1nc(-c2cccc3ccccc23)c(F)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 3/20 0.57
TGFBR1 P36897 2/20 0.54
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
MMP14 P50281 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPY5R Q15761 1/20 0.41
CHEK1 O14757 1/20 0.41
DAPK3 O43293 1/20 0.41
LTK P29376 1/20 0.41
MAPK8 P45983 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK8 P49336 1/20 0.41
LIMK1 P53667 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23618144 0.81 MPL (0.48) MPLTGFBR1LMNAMAPTMEN1
SCHEMBL23610339 0.80 TGFBR1 (0.54) MPLTGFBR1LMNAMAPTMEN1
SCHEMBL23610349 0.80 TGFBR1 (0.54) TGFBR1LMNAMAPTMEN1MAPK1
SCHEMBL6385170 0.80 HTR6 (0.55) MPLTGFBR1LMNAMAPTMEN1
SCHEMBL23618152 0.80 TGFBR1 (0.50) MPLTGFBR1LMNAMAPTMEN1
SCHEMBL1915184 0.79 MYC (0.57) MPLLMNAMAPTMEN1MAPK1
SCHEMBL6389273 0.76 TGFBR1 (0.53) TGFBR1LMNAMAPTMEN1MAPK1
SCHEMBL13198747 0.73 ALDH1A1 (0.63) MPLLMNAMAPTMEN1MAPK1
SCHEMBL6341548 0.70 ALDH1A1 (0.57) MAPTMEN1MAPK1KMT2ATDP1
SCHEMBL23610359 0.70 MPL (0.57) MPLLMNAMAPTMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME GAP43, NLN, SMN1; SMN2 MPL 4766/4885TGFBR1 4856/4885LMNA 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.